Exploring personalized neoadjuvant therapy selection strategies in breast cancer: an explainable multi-modal response modelResearch in context

QR Code

Exploring personalized neoadjuvant therapy selection strategies in breast cancer: an explainable multi-modal response modelResearch in context

Summary: Background: Neoadjuvant therapy (NAT) regimens for breast cancer are generally determined according to cancer stage and molecular subtypes without fully considering the inter-patient variability, which may lead to inefficiency or overtreatment. Artificial intelligence (AI) may support pers...

Full description

Saved in:

Bibliographic Details
Main Authors:	Luyi Han, Tianyu Zhang, Anna D'Angelo, Anna van der Voort, Katja Pinker-Domenig, Marleen Kok, Gabe Sonke, Yuan Gao, Xin Wang, Chunyao Lu, Xinglong Liang, Jonas Teuwen, Tao Tan, Ritse Mann
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	EClinicalMedicine
Subjects:	Breast cancer Neoadjuvant therapy Precise medicine Multi-modal learning Explainable artificial intelligence
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537025002883
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

Pre Hoc and Co Hoc Explainability: Frameworks for Integrating Interpretability into Machine Learning Training for Enhanced Transparency and Performance
by: Cagla Acun, et al.
Published: (2025-07-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

Neoadjuvant systemic therapy for patients with gastric cancer: Current concepts and outcomes
by: Fatih Selcukbiricik, et al.
Published: (2016-01-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Modern principles of neoadjuvant therapy for rectal cancer
by: A. M. Karachun, et al.
Published: (2025-05-01)

Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options
by: Yu. S. Sidorenko, et al.
Published: (2014-07-01)

Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.
Published: (2025-05-01)

NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)

Assessment of the safety and feasibility of neoadjuvant chemotherapy (2 cycles of FLOT chemotherapy + chemoradiotherapy) followed by surgery in the treatment of locally advanced gastric cancer
by: D. Yu. Mironova, et al.
Published: (2024-03-01)

A case of primary pulmonary leiomyosarcoma completely resected after neoadjuvant chemotherapy
by: Kazuhisa Tanaka, et al.
Published: (2019-05-01)

Assessment of the Effect of Treatment with Neoadjuvant Chemotherapy on Breast Cancer Axillary Lymph Node
by: Savelina Popovska, et al.
Published: (2013-12-01)

Explainability and Interpretability in Concept and Data Drift: A Systematic Literature Review
by: Daniele Pelosi, et al.
Published: (2025-07-01)

First case report of neoadjuvant gemcitabine and S-1 for locally advanced unresectable duodenal adenocarcinoma
by: Jiro Kimura, et al.
Published: (2022-05-01)

Transvaginal color Doppler ultrasound for monitoring the response to neoadjuvant chemotherapy in advanced cervical cancer
by: Pantaleo Greco, et al.
Published: (1997-02-01)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
by: V. A. Grigorenko, et al.
Published: (2021-07-01)

Effects of the Intestinal Microbiome and Metabolites on Neoadjuvant Chemotherapy Efficacy in Breast Cancer
by: Jingyue Fu, et al.
Published: (2025-07-01)

NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER. MODERN METHODS AND PATIENTS SELECTION CRITERIA
by: A. E. Solopova, et al.
Published: (2016-09-01)

Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
by: Yoshitaka Shimamaki, et al.
Published: (2024-02-01)

Surgical treatment outcomes in patients with non-small cell lung cancer treated with neoadjuvant systemic therapy. A pilot single-center retrospective study
by: A. V. Levitskiy, et al.
Published: (2025-05-01)

Spleen-preserving D2 subtotal distal resection of the stomach and corpocaudal resection of the pancreas after neoadjuvant induction chemotherapy and chemoradiotherapy: case report and literature review
by: V. Yu. Skoropad, et al.
Published: (2022-11-01)

NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-02-01)

Neoadjuvant personalized cancer vaccines: the final frontier?
by: Guilhem Richard, et al.
Published: (2024-12-01)

Short-term outcomes of neoadjuvant chemotherapy in colorectal cancer patients with isolated liver metastasis
by: A. Yu. Dobrodeev, et al.
Published: (2023-01-01)

CLINICAL-IMMUNOLOGICAL ASSESSMENT OF EFFICACY OF NEOADJUVANT PHOTODYNAMIC THERAPY IN SURGICAL MANAGEMENT OF PRIMARY MELANOMA
by: G. I. Gafton, et al.
Published: (2016-02-01)

Total neoadjuvant chemotherapy according to the FOLFIRINOX regimen for locally advanced adenocarcinoma of the stomach and cardioesophageal junction: interim results
by: M. V. Sedova, et al.
Published: (2023-09-01)

Clinical Outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based Clinical Review
by: Waluyo Sugito, et al.
Published: (2022-04-01)

CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC
by: Jay M. Lee, MD, et al.
Published: (2025-08-01)

Neoadjuvant PD-1 blockade induces the autophagy of immune cells: a new target for synergistic therapy of recurrent glioblastoma
by: Zixue Xuan, et al.
Published: (2025-09-01)

Nodal Downstaging of Esophageal Cancer After Neoadjuvant Therapy: A Cohort Study and Meta‐Analysis
by: Feng Su, et al.
Published: (2025-02-01)

PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2020-07-01)

Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy
by: Daigo Kobayashi, et al.
Published: (2018-09-01)

Comparison of Neoadjuvant Chemotherapy With FLOT and Modified DCF Regimens in Nonmetastatic Gastric Adenocarcinoma
by: Mehdi Pourghasemian, et al.
Published: (2025-06-01)

Diagnostic Accuracy of Post-Neoadjuvant Treatment Restaging Magnetic Resonance Imaging in Rectal Cancer in the Era of Total Neoadjuvant Treatment
by: Gaurav Ravi Kumar, et al.
Published: (2025-05-01)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01)

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy
by: Apar Pataer, et al.
Published: (2018-06-01)

Opportunities and limitations of CT - assessment of neoadjuvant chemoradiation therapy of gastric cancer
by: T. A. Agababyan, et al.
Published: (2019-12-01)

Clinical experience in the neoadjuvant treatment of unresectable differentiated thyroid cancer with the lenvatinib
by: E. B. Vasilyeva, et al.
Published: (2024-06-01)